Insufficient lymph node assessment in gastric adenocarcinoma

Journal of the Egyptian National Cancer Institute

Table 5 The status of lymph nodes assessment in resected gastric adenocarcinoma in major reported series in the literature

Authors	No. of patients	Stage	Median age	Mean TLN	Median TLNE	Mean % of stage III	% of ALNE
Biffi et al. [1]	114	I–II	63	NR	22	NR	78.9
Bouvier et al. [6]	749	I–III	68	8.4	NR	NR	17.6
Bruno et al. [10]	367	I–IV	67	17.4	15	32.6	NR
Chen et al. [7]	1101	I–IV	58	NR	NR	35.8	68.5
Coburn et al. [14]	10,807	I–IV	70	NR	9	27.5	29
Deng et al. [12]	196	II–IV	69	15.7	NR	NR	75
Gholami et al. [18]	742	I–III	65	NR	NR	15.5	65
Giuliani et al. [11]	154	I–III	65	22.6	NR	NR	NR
Huang et al. [8]	634	I–IV	NR	NR	NR	44.2	83.1
Huang et al. [22]	236	I–IV	58	23.8	23	NR	84.7
Ichikura et al. [9]	925	I–IV	57	32	30	16.4	77
Lee et al. [13]	4789	I–IV	54	31.9	30	28	94.2
Marubini et al. [2]	615	I–IV	NR	NR	NR	39.8	73.2
Schwarz and Smith [15]	1377	II–III	68	NR	17	48.4	74.7
Shen et al. [16]	1637	I–IV	65	NR	19	54.7	81.4
Smith et al. [21]	3793	I–II	71	NR	8	NR	25
Zhao et al. [4]	227	I	57	18.51	NR	NR	55.5
Present study	449	I–III	60	11.1	9	58.3	21.2
Total	28,912	I–V	65.4	27.7	15.1	31.7	51.7